BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. is a Private limited company (Ltd.) registered in United States under 0866078, and its current status with North Carolina Secretary of State is active. The company was incorporated on 12 September 2006 and lists its registered address as Durham, United States. 1 shareholder is on record for BioCryst Pharmaceuticals, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from North Carolina Secretary of State and was last updated on 3 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for BioCryst Pharmaceuticals, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Fidelity Salem Street Trust-Fidelity Small Cap Index Fund, holding 1.6% — the largest recorded stake.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.6% | North Carolina Secretary of State |
Officers
5
The Chief Data & Insights Officer of BioCryst Pharmaceuticals, Inc. currently on record is Jinky Ang Rosselli; five officers are currently on record for BioCryst Pharmaceuticals, Inc., filed with North Carolina Secretary of State.
The register reports 18 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at BioCryst Pharmaceuticals, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
BioCryst Pharmaceuticals, Inc. has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 4 subsidiaries span United States, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 4 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
BioCryst Pharmaceuticals, Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns BioCryst Pharmaceuticals, Inc.?
One shareholder is currently on record for BioCryst Pharmaceuticals, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Fidelity Salem Street Trust-Fidelity Small Cap Index Fund, holding 1.6% — the largest recorded stake. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is BioCryst Pharmaceuticals, Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for BioCryst Pharmaceuticals, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does BioCryst Pharmaceuticals, Inc. have on record?
1 shareholder is shown on record for BioCryst Pharmaceuticals, Inc..
What is BioCryst Pharmaceuticals, Inc.'s company registration number?
BioCryst Pharmaceuticals, Inc.'s registration number is 0866078, filed with North Carolina Secretary of State in United States. Its current status on the register is active.
Is BioCryst Pharmaceuticals, Inc. still an active company?
BioCryst Pharmaceuticals, Inc.'s status on North Carolina Secretary of State is listed as active.
When was BioCryst Pharmaceuticals, Inc. incorporated?
BioCryst Pharmaceuticals, Inc. was incorporated on 12 September 2006, according to North Carolina Secretary of State.
What is BioCryst Pharmaceuticals, Inc.'s registered address?
The registered address on file for BioCryst Pharmaceuticals, Inc. is Durham, United States.
What legal structure is BioCryst Pharmaceuticals, Inc. registered as?
BioCryst Pharmaceuticals, Inc. is registered as a Private limited company (Ltd.) in United States.
Who are the officers/directors of BioCryst Pharmaceuticals, Inc.?
The Chief Data & Insights Officer of BioCryst Pharmaceuticals, Inc. currently on record is Jinky Ang Rosselli; five officers are currently on record for BioCryst Pharmaceuticals, Inc., filed with North Carolina Secretary of State. Management authority at BioCryst Pharmaceuticals, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does BioCryst Pharmaceuticals, Inc. have a parent company or subsidiaries?
BioCryst Pharmaceuticals, Inc. has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 2 jurisdictions. Those 4 subsidiaries span United States, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 4 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to BioCryst Pharmaceuticals, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from North Carolina Secretary of State. Zavia's monitoring API can track changes to BioCryst Pharmaceuticals, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access BioCryst Pharmaceuticals, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like BioCryst Pharmaceuticals, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from North Carolina Secretary of State and was last synced on 3 October 2026.